Cancer Cells vs. Normal Cells: How Are They Different?

There are many differences between cancer cells and normal cells. Some of the differences are well known, whereas others have only been recently discovered and are less well understood. You may be interested in how cancer cells are different as you are coping with your own cancer or that of a loved one.

For researchers, understanding how cancer cells function differently from normal cells lays the foundation for developing treatments designed to rid the body of cancer cells without damaging normal cells.

The first portion of this list discusses the basic differences between cancer cells and healthy cells. For those who are interested in some of the more difficult-to-understand differences, the second portion of this list is more technical.

Regulation of Cell Growth

A brief explanation of the proteins in the body that regulate cell growth is also helpful in understanding cancer cells. Our DNA carries genes that in turn are the blueprint for proteins produced in the body.

Some of these proteins are growth factors, chemicals that tell cells to divide and grow. Other proteins work to suppress growth.

Mutations in particular genes (for example, those caused by tobacco smoke, radiation, ultraviolet radiation, and other carcinogens) can result in the abnormal production of proteins. Too many may be produced, or not enough, or it could be that the proteins are abnormal and function differently.

Cancer is a complex disease, and it is usually a combination of these abnormalities that lead to a cancerous cell, rather than a single mutation or protein abnormality.

Difference Between Cancerous and Normal Cells
© Verywell, 2017.

Cancer Cells vs. Normal Cells

Below are some of the major differences between normal cells and cancer cells, which in turn account for how malignant tumors grow and respond differently to their surroundings than benign tumors.


Normal cells stop growing (reproducing) when enough cells are present. For example, if cells are being produced to repair a cut in the skin, new cells are no longer produced when there are enough cells present to fill the hole (when the repair work is done).

In contrast, cancer cells don’t stop growing when there are enough cells present. This continued growth often results in a tumor (a cluster of cancer cells) being formed.

Each gene in the body carries a blueprint that codes for a different protein. Some of these proteins are growth factors—chemicals that tell cells to grow and divide. If the gene that codes for one of these proteins is stuck in the “on” position by a mutation (an oncogene) the growth factor proteins continue to be produced. In response, the cells continue to grow.


Cancer cells don’t interact with other cells as normal cells do. Normal cells respond to signals sent from other nearby cells that say, essentially, “you’ve reached your boundary.” When normal cells “hear” these signals they stop growing. Cancer cells do not respond to these signals.

Cell Repair and Cell Death

Normal cells are either repaired or die (undergo apoptosis) when they are damaged or get old. Cancer cells are either not repaired or do not undergo apoptosis.

For example, one protein called p53 has the job of checking to see if a cell is too damaged to repair, and if so, advise the cell to kill itself. If this protein p53 is abnormal or inactive (for example, from a mutation in the p53 gene), then old or damaged cells are allowed to reproduce.

The p53 gene is one type of tumor suppressor gene that code for proteins that suppress the growth of cells.


Normal cells secrete substances that make them stick together in a group. Cancer cells fail to make these substances, and can “float away” to locations nearby, or through the bloodstream or system of lymph channels to distant regions in the body.

Ability to Metastasize (Spread)

Normal cells stay in the area of the body where they belong. For example, lung cells remain in the lungs. Some cancer cells may lack the adhesion molecules that cause stickiness, and are able to detach and travel via the bloodstream and lymphatic system to other regions of the body—they have the ability to metastasize.

Once they arrive in a new region (such as lymph nodes, the lungs, the liver, or the bones) they begin to grow, often forming tumors far removed from the original tumor.


Under a microscope, normal cells and cancer cells may look quite different. In contrast to normal cells, cancer cells often exhibit much more variability in cell size—some are larger than normal and some are smaller than normal.

In addition, cancer cells often have an abnormal shape, both of the cell, and of the nucleus (the “brain” of the cell.) The nucleus appears both larger and darker than normal cells.

The reason for the darkness is that the nucleus of cancer cells contains excess DNA. Up close, cancer cells often have an abnormal number of chromosomes that are arranged in a disorganized fashion.

The Rate of Growth

Normal cells reproduce themselves and then stop when enough cells are present. Cancer cells reproduce rapidly before the cells have had a chance to mature.


Normal cells mature. Cancer cells, because they grow rapidly and divide before cells are fully mature, remain immature. Doctors use the term undifferentiated to describe immature cells (in contrast to differentiated to describe more mature cells.)

Another way to explain this is to view cancer cells as cells that don’t “grow up” and specialize into adult cells. The degree of maturation of cells corresponds to the grade of cancer. Cancers are graded on a scale from 1 to 3 with 3 being the most aggressive.

Evading the Immune System

When normal cells become damaged, the immune system (via cells called lymphocytes) identifies and removes them.

Cancer cells are able to evade (trick) the immune system long enough to grow into a tumor by either by escaping detection or by secreting chemicals that inactivate immune cells that come to the scene. Some of the newer immunotherapy medications address this aspect of cancer cells.


Normal cells perform the function they are meant to perform, whereas cancer cells may not be functional.

For example, normal white blood cells help fight off infections. In leukemia, the number of white blood cells may be very high, but since the cancerous white blood cells are not functioning as they should, people can be more at risk for infection even with an elevated white blood cell count.

The same can be true of substances produced. For example, normal thyroid cells produce thyroid hormone. Cancerous thyroid cells (thyroid cancer) may not produce thyroid hormone. In this case, the body may lack enough thyroid hormone (hypothyroidism) despite an increased amount of thyroid tissue.

Blood Supply

Angiogenesis is the process by which cells attract blood vessels to grow and feed the tissue. Normal cells undergo a process called angiogenesis only as part of normal growth and development and when new tissue is needed to repair damaged tissue.

Cancer cells undergo angiogenesis even when growth is not necessary. One type of cancer treatment involves the use of angiogenesis inhibitors—medications that block angiogenesis in the body in an effort to keep tumors from growing.

More Differences

This list contains further differences between healthy cells and cancer cells. For those who wish to skip these technical points, please skip to the next subheading labeled summarizing the differences.

Evading Growth Suppressors

Normal cells are controlled by growth (tumor) suppressors. There are three main types of tumor suppressor genes that code for proteins that suppress growth.

One type tells cells to slow down and stop dividing. One type is responsible for fixing changes in damaged cells. The third type is in charge of the apoptosis noted above. Mutations that result in any of these tumor suppressor genes being inactivated allow cancer cells to grow unchecked.


Normal cells listen to signals from neighboring cells and stop growing when they encroach on nearby tissues (something called contact inhibition). Cancer cells ignore these cells and invade nearby tissues.

Benign (noncancerous) tumors have a fibrous capsule. They may push up against nearby tissues but they do not invade/intermingle with other tissues.

Cancer cells, in contrast, don’t respect boundaries and invade tissues. This results in the fingerlike projections that are often noted on radiologic scans of cancerous tumors. The word cancer, in fact, comes from the Latin word for crab used to describe the crablike invasion of cancers into nearby tissues.

Energy Source

Normal cells get most of their energy (in the form of a molecule called ATP) through a process called the Krebs cycle, and only a small amount of their energy through a different process called glycolysis.

Many types of cancer cells produce their energy through glycolysis despite the presence of oxygen (Warburg phenomenon). Thus, the reasoning behind hyperbaric oxygen therapy is flawed. Sometimes hyperbaric oxygen may induce cancer growth.


Normal cells are mortal, that is, they have a lifespan. Cells aren’t designed to live forever, and just like the humans they are present in, cells grow old. Researchers are beginning to look at something called telomeres, structures that hold DNA together at the end of the chromosomes, for their role in cancer.

One of the limitations to growth in normal cells is the length of the telomeres. Every time a cell divides, the telomeres get shorter. When the telomeres become too short, a cell can no longer divide and the cell dies.

Cancer cells have figured out a way to renew telomeres so that they can continue to divide. An enzyme called telomerase works to lengthen the telomeres so that the cell can divide indefinitely—essentially becoming immortal.

Ability to "Hide"

Many people wonder why cancer can recur years, and sometimes decades after it appears to be gone (especially with tumors such as estrogen receptor-positive breast cancers). There are several theories about why cancers may recur.

In general, it's thought that there is a hierarchy of cancer cells, with some cells (cancer stem cells) having the ability to resist treatment and lie dormant. This is an active area of research, and extremely important.

Genomic Instability

Normal cells have normal DNA and a normal number of chromosomes. Cancer cells often have an abnormal number of chromosomes and the DNA becomes increasingly abnormal as it develops a multitude of mutations.

Some of these are driver mutations, meaning they drive the transformation of the cell to be cancerous. Many of the mutations are passenger mutations, meaning they don’t have a direct function for the cancer cell.

For some cancers, determining which driver mutations are present (molecular profiling or gene testing) allows physicians to use targeted medications which specifically target the growth of the cancer.

The development of targeted therapies such as EGFR inhibitors for cancers with EGFR mutations is one of the more rapidly growing and progressing areas of cancer treatment.

How a Cell Becomes Cancerous

As noted above, there are many differences between normal cells and cancer cells. Also noteworthy is the number of “checkpoints” that need to be bypassed for a cell to become cancerous:

  • The cell needs to have growth factors that prompt it to grow even when growth is not necessary.
  • The cells has to evade proteins that direct cells to stop growing and die when they become abnormal.
  • The cell needs to evade signals from other cells,
  • The cells need to lose the normal “stickiness” (adhesion molecules) that normal cells produce.

All in all, it is very difficult for a normal cell to become cancerous, which may seem surprising considering that one in three people will develop cancer in their lifetime.

The explanation is that in the normal body, roughly three billion cells divide every single day. “Accidents” in the reproduction of the cells caused by heredity or carcinogens in the environment during any of those divisions can create a cell that, following further mutations, can develop into a cancer cell.

As noted above, there are many differences in cancer cells and normal cells which make up either benign or malignant tumors. In addition, there are ways that tumors containing cancer cells or normal cells behave in the body.

The Concept of Cancer Stem Cells

After discussing these many differences between cancer cells and normal cells, you may be wondering if there are differences between cancer cells themselves. That there may be a hierarchy of cancer cells—some having different functions than others—is the basis of discussions looking at cancer stem cells as discussed above. 

We still don't understand how cancer cells can seemingly hide for years or decades and then reappear. It's thought by some that the "generals" in the hierarchy of cancer cells referred to as cancer stem cells may be more resistant to treatments and have the ability to lie dormant when other soldier cancer cells are eliminated by treatments such as chemotherapy.

While we currently treat all the cancer cells in a tumor as being identical, it's likely that in the future treatments will take into further consideration some of the differences in cancer cells in an individual tumor.

A Word from Verywell

Many people become frustrated, wondering why we haven't yet found a way to stop all cancers in their tracks. Understanding the many changes a cell undergoes in the process of becoming a cancer cell can help explain some of the complexity. There is not one step, but rather many, that are currently being addressed in different ways.

In addition, cancer isn't a single disease, but rather hundreds of different diseases. And even two cancers that are the same with regard to type and stage, can behave very differently. If there were 200 people with the same type and stage of cancer in a room, they would have 200 different cancers from a molecular standpoint.

It is helpful, however, to know that as we learn more about what makes a cancer cell a cancer cell, we gain more insight into how to stop that cell from reproducing, and perhaps even making the transition to becoming a cancer cell in the first place.

Progress is already being made in that arena, as targeted therapies are being developed which discriminate between cancer cells and normal cells in their mechanism.

And research on immunotherapy is just as exciting, as we are finding ways to "stimulate" our own immune systems to do what they already know how to do—find cancer cells and eliminate them.

Figuring out the ways in which cancer cells "disguise" themselves and hide has resulted in better treatments, and uncommonly, complete remissions, for some people with the most advanced solid tumors.

Was this page helpful?
9 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Alexandrov LB, Ju YS, Haase K, et al. Mutational signatures associated with tobacco smoking in human cancer. Science. 2016;354(6312):618-622. doi:10.1126/science.aag0299

  2. Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer. 2012;12(4):237-51. doi:10.1038/nrc3237

  3. Chandran R, Hakki M, Spurgeon S. Infections in Leukemia. In: Azevedo L, editor. Sepsis: An Ongoing and Significant Challenge. IntechOpen; 2012. doi:10.5772/50193

  4. Carter Y, Sippel RS, Chen H. Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management. Oncologist. 2014;19(1):34-43. doi:10.1634/theoncologist.2013-0237

  5. Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer--a review. Target Oncol. 2012;7(4):233-42. doi:10.1007/s11523-012-0233-x

  6. Artandi SE, Depinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010;31(1):9-18. doi:10.1093/carcin/bgp268

  7. Wheeler DL, Dunn EF, Harari PM. Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol. 2010;7(9):493-507. doi:10.1038/nrclinonc.2010.97

  8. American Cancer Society. Lifetime Risk of Developing or Dying From Cancer.

  9. National Cancer Institute. Cancer-Causing Substances in the Environment.

Additional Reading